To investigate whether the enhanced PDAC proliferation via PPARγ-inhibited mitophagic pathway has effects on stemness of pancreatic cancer cells and chemotherapy sensitivity, we detected the expression of PaCSCs’ markers. This evidence concerns the gene PPARG and familial pancreatic carcinoma.